Wolin, E., Mita, A., Mahipal, A., Meyer, T., Bendell, J., Nemunaitis, J., . . . Mita, M. (2019). A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
Citação norma ChicagoWolin, Edward, et al. A Phase 2 Study of an Oral MTORC1/mTORC2 Kinase Inhibitor (CC-223) for Non-pancreatic Neuroendocrine Tumors With or Without Carcinoid Symptoms. 2019.
Citação norma MLAWolin, Edward, et al. A Phase 2 Study of an Oral MTORC1/mTORC2 Kinase Inhibitor (CC-223) for Non-pancreatic Neuroendocrine Tumors With or Without Carcinoid Symptoms. 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.